Zions Bancorp N.A. (0M3L)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 66.36 |
|---|---|
| 52-week range | 48.43 – 73.50 |
| Return, 1 month / 3 months | +3.5% / −4.8% |
| Return, 1 year / 3 years | +32.2% / +144.1% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 31.4% |
| Worst drawdown (1 year) | -18.1% |
| Average daily value traded | 0.03M USD |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zions Bancorporation is a bank holding company based in Salt Lake City, Utah, that provides commercial and retail banking through a family of subsidiary banks operating across the western United States. It serves small and mid-sized businesses, professionals and individual customers with deposit accounts, commercial and consumer loans, treasury management, and wealth and trust services. Its banks operate under local names in their home regions, giving customers a community bank feel backed by a larger organisation.
Zions Bancorp N.A. trades under the code 0M3L on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zions Bancorp N.A. (0M3L) trades on the London Exchange in UK. It last closed at USD 66.36 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,463 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.2% and over the last three months it fell 4.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.2% | ||
| From 52-week high | -9.1% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.8% | ||
| 6-month return | 8.2% | ||
| 12-month return, skipping the last month | 27.6% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.1% | ||
| Liquidity | 21 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.1% |
|---|---|
| 1 month | +3.5% |
| 3 months | −4.8% |
| 6 months | +8.2% |
| 1 year | +32.2% |
| 3 years | +144.1% |
| 5 years | +20.7% |
Signals
| 50-day / 200-day average | 65.94 / 63.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 1.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Aug 2026 | USD 0.4800 |
| 14 May 2026 | USD 0.4500 |
| 11 Feb 2026 | USD 0.4500 |
| 12 Nov 2025 | USD 0.4500 |
| 13 Aug 2025 | USD 0.4500 |
| 15 May 2025 | USD 0.4300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.